ReportGem ReportGem

GLOBAL RESEARCH ARCHIVE

RD Saúde 2Q26 — Solid And Healthy Print In-Line With Constructive Expectations; Remain OW

Published: 2026-08-05Institution: JPMorganCompany / ticker: RADL3.SAPages: 8Original language: 英语
RADL3.SA coverageJPMorgan research

Research evidence excerpt

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.

Open report viewer

Related research and intelligence

Raia Drogasil SA: Cash Generation and GLP-1 Signal Outshines Slightly Weaker Bottom-line2026-08-05 · Morgan StanleyRD Saúde 2Q26 – Conference Call Highlights2026-08-05 · JPMorganSmartStop Good Expense Trends Help Drive 2Q FFO Upside and Guidance Increase2026-08-05 · JPMorganCushman & Wakefield 2Q Top Line/EBITDA Beat, Guidance Raised; Strong Leasing Offset Particularly Weak Capital Markets2026-08-05 · JPMorganUnicharm (8113) 2Q results: Watching specific measures on price pass-through and likelihood from 3Q onward2026-08-05 · JPMorganOil and Natural Gas Corporation 1Q: In-line EBITDA driven by higher oil prices; volumes weak2026-08-05 · JPMorgan